Comments
Loading...

AN2 Therapeutics

ANTXNASDAQ
Logo brought to you by Benzinga Data
$1.07
0.010.94%
Pre-Market: 7:39 PM EDT
15 minutes delayed

AN2 Therapeutics (NASDAQ:ANTX) Stock, Earnings Estimates, EPS, And Revenue

AN2 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS Estimate
$-0.370
Quarterly Revenue Estimate
Annual Revenue
(as of Jun 30)

Analyze the earnings history of AN2 Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

AN2 Therapeutics (ANTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-13$-0.48$-0.5918.6 %
Mar 20242024-05-14$-0.56$-0.629.68 %
Dec 20232024-03-28$-0.57$-0.7625.0 %
Sep 20232023-11-09$-0.65$-0.707.14 %

AN2 Therapeutics (ANTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is AN2 Therapeutics (NASDAQ:ANTX) reporting earnings?

A

AN2 Therapeutics (ANTX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for AN2 Therapeutics (NASDAQ:ANTX)?

A

The Actual EPS was $-0.48, which beat the estimate of $-0.59.

Q

What were AN2 Therapeutics’s (NASDAQ:ANTX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch